Aemetis, Inc.
Aemetis, Inc. is an enterprise specializing in renewable natural gas and sustainable fuels, conducting operations across North America and India. The company's business activities are structured into three primary divisions: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. A core objective for…
1D
+0.7%
1W
-12.0%
1M
-23.2%
6M
-35.7%
YTD
+5.0%
1Y
-49.3%
2Y
-48.0%
5Y
-91.9%
10Y
+13.2%
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~2% weaker price swings than usual
PRICE TARGET LOW
US$1.75
CONSENSUS
US$3.17
MEDIAN
US$3.50
PRICE TARGET HIGH
US$4.25
0
STRONG BUY
5
BUY
1
HOLD
1
SELL
0
STRONG SELL
7
TOTAL · Buy
As of: 20/08/2026
P/E
-1.6
P/B
-0.32
EV/EBITDA
-31.22
RETURN ON EQUITY
2.9%
NET MARGIN
-14.9%
DEBT/EQUITY
-1.3
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
93.1%
FLOAT SHARES
67,163,123
AVG. DAILY VOLUME (30D)
792,236
Simon Timothy Alan
Aemetis, Inc. is a company in the Basic Materials sector, Chemicals - Specialty industry, headquartered in United States.
The CEO is Eric A. McAfee, the company employs around 220 people.
The IPO was on 27/06/2006; the stock trades on NASDAQ under the ticker AMTX.
7 analysts rate the stock, the consensus is Buy (as of 20/08/2026).
The average price target is US$3.17, ranging from US$1.75 to US$4.25, with a median of US$3.50.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly -2% stronger than usual.
No, Aemetis currently does not pay a dividend.
Comparable stocks include Ecolab, Sherwin-Williams Company, Air Products and Chemicals, PPG Industries, International Flavors & Fragrances, Albemarle, NewMarket and Axalta Coating Systems.
Clicking "Analyze stock" lets five strategies assess Aemetis against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.